INS and polycystic ovary syndrome: Despite the similar serum glucose and lipid metabolic parameters in the study, fasting C-peptide, fasting insulin, homeostatic model assessment for insulin resistance (HOMA-IR), and androgen levels were notably higher in patients with both MASLD and PCOS than in MASLD patients without PCOS (P < 0.001) (Supplementary Table S1).